- Home
- RMTI vs NVCT Comparison
RMTI vs NVCT Comparison
Compare RMTI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- NVCT
- Stock Information
- Founded
- RMTI 1994
- NVCT 2020
- Country
- RMTI United States
- NVCT United States
- Employees
- RMTI 237
- NVCT N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- RMTI Health Care
- NVCT Health Care
- Exchange
- RMTI Nasdaq
- NVCT Nasdaq
- Market Cap
- RMTI 71.1M
- NVCT 119.4M
- IPO Year
- RMTI 1998
- NVCT 2022
- Fundamental
- Price
- RMTI $2.20
- NVCT $4.90
- Analyst Decision
- RMTI Strong Buy
- NVCT Strong Buy
- Analyst Count
- RMTI 2
- NVCT 1
- Target Price
- RMTI $7.00
- NVCT $21.00
- AVG Volume (30 Days)
- RMTI 1.2M
- NVCT 303.6K
- Earning Date
- RMTI 11-12-2024
- NVCT 11-05-2024
- Dividend Yield
- RMTI N/A
- NVCT N/A
- EPS Growth
- RMTI N/A
- NVCT N/A
- EPS
- RMTI N/A
- NVCT N/A
- Revenue
- RMTI $98,917,000.00
- NVCT N/A
- Revenue This Year
- RMTI $22.20
- NVCT N/A
- Revenue Next Year
- RMTI $8.76
- NVCT N/A
- P/E Ratio
- RMTI N/A
- NVCT N/A
- Revenue Growth
- RMTI 22.37
- NVCT N/A
- 52 Week Low
- RMTI $1.16
- NVCT $4.69
- 52 Week High
- RMTI $5.15
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- RMTI 30.39
- NVCT 35.71
- Support Level
- RMTI $2.27
- NVCT $4.75
- Resistance Level
- RMTI $2.59
- NVCT $5.49
- Average True Range (ATR)
- RMTI 0.34
- NVCT 1.14
- MACD
- RMTI -0.18
- NVCT -0.52
- Stochastic Oscillator
- RMTI 1.67
- NVCT 3.02
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.